Opinion: An Existing Drug to Assess In Vivo for Potential Adjunctive Therapy of Ebola Virus Disease and Post-Ebola Syndrome

Opinion: An Existing Drug to Assess In Vivo for Potential Adjunctive Therapy of Ebola Virus Disease and Post-Ebola Syndrome

Bibliographic Details
Main Authors: Katherine Hendricks, Meredith Gilman Parrado, John Bradley
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-01-01
Series:Frontiers in Pharmacology
Subjects:
Ebola virus disease
minocycline
drug discovery
cytokine
chemokine
hepatoprotection
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.01691/full
id doaj-7bc861fbde19481284d649b153ed2493
record_format Article
spelling doaj-7bc861fbde19481284d649b153ed24932020-11-25T01:29:16ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122020-01-011010.3389/fphar.2019.01691508969Opinion: An Existing Drug to Assess In Vivo for Potential Adjunctive Therapy of Ebola Virus Disease and Post-Ebola SyndromeKatherine Hendricks0Meredith Gilman Parrado1John Bradley2Independent researcher, Atlanta, GA, United StatesIndependent researcher, Atlanta, GA, United StatesDivision of Infectious Diseases, Department of Pediatrics, UCSD School of Medicine, San Diego, CA, United Stateshttps://www.frontiersin.org/article/10.3389/fphar.2019.01691/fullEbola virus diseaseminocyclinedrug discoverycytokinechemokinehepatoprotection
collection DOAJ
language English
format Article
sources DOAJ
author Katherine Hendricks
Meredith Gilman Parrado
John Bradley
spellingShingle Katherine Hendricks
Meredith Gilman Parrado
John Bradley
Opinion: An Existing Drug to Assess In Vivo for Potential Adjunctive Therapy of Ebola Virus Disease and Post-Ebola Syndrome
Frontiers in Pharmacology
Ebola virus disease
minocycline
drug discovery
cytokine
chemokine
hepatoprotection
author_facet Katherine Hendricks
Meredith Gilman Parrado
John Bradley
author_sort Katherine Hendricks
title Opinion: An Existing Drug to Assess In Vivo for Potential Adjunctive Therapy of Ebola Virus Disease and Post-Ebola Syndrome
title_short Opinion: An Existing Drug to Assess In Vivo for Potential Adjunctive Therapy of Ebola Virus Disease and Post-Ebola Syndrome
title_full Opinion: An Existing Drug to Assess In Vivo for Potential Adjunctive Therapy of Ebola Virus Disease and Post-Ebola Syndrome
title_fullStr Opinion: An Existing Drug to Assess In Vivo for Potential Adjunctive Therapy of Ebola Virus Disease and Post-Ebola Syndrome
title_full_unstemmed Opinion: An Existing Drug to Assess In Vivo for Potential Adjunctive Therapy of Ebola Virus Disease and Post-Ebola Syndrome
title_sort opinion: an existing drug to assess in vivo for potential adjunctive therapy of ebola virus disease and post-ebola syndrome
publisher Frontiers Media S.A.
series Frontiers in Pharmacology
issn 1663-9812
publishDate 2020-01-01
topic Ebola virus disease
minocycline
drug discovery
cytokine
chemokine
hepatoprotection
url https://www.frontiersin.org/article/10.3389/fphar.2019.01691/full
work_keys_str_mv AT katherinehendricks opinionanexistingdrugtoassessinvivoforpotentialadjunctivetherapyofebolavirusdiseaseandpostebolasyndrome
AT meredithgilmanparrado opinionanexistingdrugtoassessinvivoforpotentialadjunctivetherapyofebolavirusdiseaseandpostebolasyndrome
AT johnbradley opinionanexistingdrugtoassessinvivoforpotentialadjunctivetherapyofebolavirusdiseaseandpostebolasyndrome
_version_ 1725097344609812480

Similar Items